1. Home
  2. About FDA
  3. FDA Organization
  4. Oncology Center of Excellence
  5. Conversations on Cancer
  1. Oncology Center of Excellence

Conversations on Cancer

The FDA Oncology Center of Excellence Conversations on Cancer is a public panel discussion series aimed at fostering dialogue about cancer-related issues, including awareness, prevention, treatment, and regulatory processes. These discussions bring together patients, advocates, academic researchers, and regulatory representatives to discuss topics such as clinical trials, drug approvals, and patient care experiences.

Upcoming Meetings

Conversations on Cancer – Oncology Nurses – Frontliners in Oncology
Date: May 6, 2026
Time: 3:00 pm-4:00 pm ET

Background: In recognition of National Nurses Week, the FDA Oncology Center of Excellence will convene a Conversations on Cancer discussion to spotlight the critical role nurses play as frontline professionals in oncology drug development through their involvement in clinical trials, research coordination, patient care, and education. While their responsibilities extend from direct patient interaction to significant contributions in the research and pharmaceutical industries, their expertise and contributions are often underrepresented and underrecognized in the drug development process. This conversation opens dialogue between frontline nurses and regulatory professionals regarding their roles in cancer treatment and how nursing insights can inform oncology product development, clinical trial participation, and the patient experience.

Webcast Information: 

A free-of-charge webcast of this program can be viewed on Wednesday, May 6, 2026, beginning at 3:00 pm EST on YouTube at: https://www.youtube.com/live/M6f-vqRp3P8External Link Disclaimer

FDA also plans to post a webcast of this Conversations on Cancer program on YouTube for on-demand viewing at: https://www.youtube.com/@US_FDA/videos

Conversations on Cancer - Patient First = Project Facilitate
Date: June 10, 2026
Time: 12:00 pm ET

Background: Project Facilitate is a dedicated resource designed to streamline access to investigational therapies for patients facing life-threatening cancers. In this session, the expert panel will explore the evolution of Project Facilitate from its inception to its current role as an essential resource for oncology practitioners nationwide, examining the concrete impact of Project Facilitate through data-driven insights. They will share cases that illustrate both common scenarios and unique challenges, providing practical guidance on how to submit a single-patient IND, highlighting common pitfalls to avoid and best practices for working with pharmaceutical companies, whose agreement is required before FDA review can proceed. Importantly, the panel will address how patient safety is maintained throughout the expanded access process, even when using investigational products whose safety and efficacy profiles are still being established.

Webcast Information: 

A free-of-charge webcast of this program can be viewed on June 10, 2026, beginning at 12:00 PM EST on YouTube at: https://www.youtube.com/live/hkmnRdL4AGE 

FDA also plans to post a webcast of this Conversations on Cancer program on YouTube for on-demand viewing at: https://www.youtube.com/@US_FDA/videos

 



Back to Top